Table 5.
miRNA | R2 | p | Classification of interaction | Source of validation/prediction |
---|---|---|---|---|
Non-metastatic tumors | ||||
hsa-miR-134_st | −0.72 | <0.001 | Predicted | miRWalk, miRDB, MiRanda, DIANAmT |
hsa-miR-3144-3p | −0.53 | 0.006 | Predicted | miRWalk, miRDB, TargetScan |
hsa-miR-4659a-5p | −0.52 | 0.007 | Predicted | miRWalk, miRDB |
hsa-miR-133b | −0.51 | 0.009 | Predicted | miRDB |
hsa-miR-651_st | −0.47 | 0.01 | Predicted | miRDB, TargetScan |
hsa-miR-27a-star_st | −0.46 | 0.02 | Predicted | miRDB, MiRanda, TargetScan |
hsa-miR-4476 | −0.42 | 0.03 | Predicted | miRDB, miRWalk,TargetScan |
hsa-miR-155_st | −0.42 | 0.03 | Predicted | miRDB, TargetScan |
hsa-miR-1227_st | −0.42 | 0.03 | Predicted | miRDB, miRWalk, TargetScan |
hsa-miR-3126-3p | −0.42 | 0.03 | Predicted | miRDB, TargetScan |
Metastatic tumors | ||||
hsa-miR-4328 | −0.71 | 0.001 | Predicted | miRDB, TargetScan, MiRanda, DIANAmT |
hsa-miR-651_st | −0.64 | 0.006 | Predicted | miRDB, TargetScan, miRWalk |
hsa-miR-3616-5p | −0.63 | 0.006 | Predicted | miRDB, TargetScan |
hsa-miR-876-3p | −0.62 | 0.008 | Predicted | miRDB, miRWalk |
hsa-miR-1233_st | −0.61 | 0.01 | Predicted | miRDB, TargetScan, miRWalk |
hsa-miR-548e_st | −0.60 | 0.01 | Predicted | miRDB |
hsa-mir-302c_st | −0.59 | 0.01 | Predicted | miRDB |
hsa-mir-373_st | −0.55 | 0.02 | Predicted | miRDB, TargetScan, miRWalk |
hsa-miR-3686 | −0.55 | 0.02 | Predicted | miRDB, TargetScan, miRWalk |
hsa-miR-19a-star_st | −0.55 | 0.02 | Predicted | miRDB, TargetScan, miRWalk |
hsa-miR-646 | −0.54 | 0.03 | Predicted | miRDB, TargetScan, miRWalk |
hsa-miR-4504 | −0.53 | 0.03 | Predicted | miRDB, TargetScan |
hsa-mir-141_st | −0.52 | 0.03 | Predicted | miRDB, TargetScan, miRWalk |
hsa-miR-4659a-5p | −0.52 | 0.03 | Predicted | miRDB, TargetScan |
R2: Pearson correlation coefficient.